Cancer stem cells, EMT, and developmental pathway activation in pancreatic tumors
S Hindriksen, MF Bijlsma - Cancers, 2012 - mdpi.com
Pancreatic cancer is a disease with remarkably poor patient survival rates. The frequent
presence of metastases and profound chemoresistance pose a severe problem for the …
presence of metastases and profound chemoresistance pose a severe problem for the …
[HTML][HTML] Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell–derived IL-6 is reversed predominantly by IL-6 blockade
R Antoon, XH Wang, AH Saleh, J Warrington… - Cytotherapy, 2022 - Elsevier
Pancreatic cancer is a highly lethal cancer characterized by local invasiveness, early
metastasis, recurrence and high resistance to current therapies. Extensive stroma or …
metastasis, recurrence and high resistance to current therapies. Extensive stroma or …
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
CA Bradley, M Salto-Tellez, P Laurent-Puig… - Nature reviews Clinical …, 2017 - nature.com
Data from many preclinical studies, including those using cellular models of colorectal,
gastric, gastro-oesophageal and gastro-oesophageal junction cancers, indicate that the …
gastric, gastro-oesophageal and gastro-oesophageal junction cancers, indicate that the …
HGF/c-MET targeted therapeutics: novel strategies for cancer medicine
TA Yap, SK Sandhu, SM Alam… - Current drug …, 2011 - ingentaconnect.com
The hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/c-MET) receptor
tyrosine kinase (RTK) pathway plays a pleotropic role in cell proliferation, migration …
tyrosine kinase (RTK) pathway plays a pleotropic role in cell proliferation, migration …
Pancreatic cancer microenvironment: a current dilemma
B Uzunparmak, IH Sahin - Clinical and translational medicine, 2019 - Springer
Pancreatic cancer is one of the leading causes of cancer-related death in the United States
and survival outcomes remain dismal despite significant advances in molecular diagnostics …
and survival outcomes remain dismal despite significant advances in molecular diagnostics …
Regulators of epithelial mesenchymal transition in pancreatic cancer
S Hamada, K Satoh, A Masamune… - Frontiers in …, 2012 - frontiersin.org
Pancreatic cancer is a leading cause of cancer-related death due to its invasive nature.
Despite the improvement of diagnostic strategy, early diagnosis of pancreatic cancer is still …
Despite the improvement of diagnostic strategy, early diagnosis of pancreatic cancer is still …
The role of stromal components in pancreatic cancer progression
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human cancers, and is
known for its extremely poor prognosis. Because of the location and composition of the …
known for its extremely poor prognosis. Because of the location and composition of the …
Targeting the hepatocyte growth factor/mesenchymal epithelial transition pathway in gastric cancer: biological rationale and clinical applications
O Abdel-Rahman - Expert Review of Anticancer Therapy, 2015 - Taylor & Francis
Advanced gastric cancer (GC) is a dreadful disease with a poor prognosis and the majority
of patients die within 1 year of diagnosis. In the past decade, important signaling pathways …
of patients die within 1 year of diagnosis. In the past decade, important signaling pathways …
Alteration of pancreatic cancer cell functions by tumor-stromal cell interaction
S Hamada, A Masamune, T Shimosegawa - Frontiers in physiology, 2013 - frontiersin.org
Pancreatic cancer shows a characteristic tissue structure called desmoplasia, which consists
of dense fibrotic stroma surrounding cancer cells. Interactions between pancreatic cancer …
of dense fibrotic stroma surrounding cancer cells. Interactions between pancreatic cancer …
Cholecystokinin receptor antagonist induces pancreatic stellate cell plasticity rendering the tumor microenvironment less oncogenic
G Jolly, T Duka, N Shivapurkar, W Chen, S Bansal… - Cancers, 2023 - mdpi.com
Simple Summary The tumor microenvironment of pancreatic cancer consists of dense
fibrotic stroma, which, to a certain extent, accounts for the relative drug resistance of this …
fibrotic stroma, which, to a certain extent, accounts for the relative drug resistance of this …